Headlands Technologies’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$495K	Buy	55,221 +51,002	+1,209%	+$457K	0.06%	303
2025 Q1	$31.6K	Buy	+4,219	New	+$31.6K	﹤0.01%	787
2024 Q3	–	Sell	-16,750	Closed	-$104K	–	1195
2024 Q2	$104K	Buy	+16,750	New	+$104K	0.01%	636